A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men

G. B. Ellsworth; S. Y. Lensing; C. B. Ogilvie; J. Y. Lee; S. E. Goldstone; J. M. Berry-Lawhorn; N. Jay; E. A. Stier; J. S. Logan; M. H. Einstein; A. Saah; R. T. Mitsuyasu; D. Aboulafia; J. M. Palefsky; T. J. Wilkin

doi:10.1016/j.pvr.2018.05.001

A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men

G. B. Ellsworth, S. Y. Lensing, C. B. Ogilvie, J. Y. Lee, S. E. Goldstone, J. M. Berry-Lawhorn, N. Jay, E. A. Stier, J. S. Logan, M. H. Einstein, A. Saah, R. T. Mitsuyasu, D. Aboulafia, J. M. Palefsky, T. J. Wilkin

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	11-14
Number of pages	4
Journal	Papillomavirus Research
Volume	6
DOIs	https://doi.org/10.1016/j.pvr.2018.05.001
State	Published - Dec 2018
Externally published	Yes

Access to Document

10.1016/j.pvr.2018.05.001

Cite this

Ellsworth, G. B., Lensing, S. Y., Ogilvie, C. B., Lee, J. Y., Goldstone, S. E., Berry-Lawhorn, J. M., Jay, N., Stier, E. A., Logan, J. S., Einstein, M. H., Saah, A., Mitsuyasu, R. T., Aboulafia, D., Palefsky, J. M., & Wilkin, T. J. (2018). A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men. Papillomavirus Research, 6, 11-14. https://doi.org/10.1016/j.pvr.2018.05.001

@article{d66251b7802542a6b04ffd7f64d9600a,

title = "A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men",

author = "Ellsworth, {G. B.} and Lensing, {S. Y.} and Ogilvie, {C. B.} and Lee, {J. Y.} and Goldstone, {S. E.} and Berry-Lawhorn, {J. M.} and N. Jay and Stier, {E. A.} and Logan, {J. S.} and Einstein, {M. H.} and A. Saah and Mitsuyasu, {R. T.} and D. Aboulafia and Palefsky, {J. M.} and Wilkin, {T. J.}",

note = "Funding Information: National Institutes of Health [K23 AI 55038 to T.J.W., UL1 RR024996 to Weill Cornell Clinical and Translational Science Center, U01 CA121947–01 to R.T.M., M01-RR00865 to Weill Cornell Clinical and Translational Science Center, T32 AI007613 to Division of Infectious Diseases of Weill Cornell Medical College, and UL1 RR024131 to University of California at San Francisco Clinical and Translational Science Institute]. Merck Laboratories provided funding for the HPV antibody assays and provided the vaccine doses for this study. Funding Information: Mark H. Einstein has advised or participated in educational speaking activities but not received an honorarium from Merck; Montefiore Medical Center had received payment for time spent by M.H.E. for these activities; Montefiore Medical Center has received grant funding from Merck for research-related costs of clinical trials for which M.H.E. was primary investigator. Alfred Saah is an employee of Merck Laboratories and owns stock in Merck Laboratories. Joel M. Palefsky has served as a consultant for Merck; University of California at San Francisco has received grant funding from Merck for advisory board activities of J.M.P. and for research-related costs of clinical trials for which J.M.P. was the primary investigator. Timothy J. Wilkin has served as an ad hoc advisor for GlaxoSmit hKl ine/ViiV Healthcare, and has received grant funding (paid to Weill Cornell Medicine) from GlaxoSmit hKl ine/ViiV Healthcare. ",

year = "2018",

month = dec,

doi = "10.1016/j.pvr.2018.05.001",

language = "English",

volume = "6",

pages = "11--14",

journal = "Papillomavirus Research",

issn = "2666-6790",

publisher = "Elsevier BV",

}

Ellsworth, GB, Lensing, SY, Ogilvie, CB, Lee, JY, Goldstone, SE, Berry-Lawhorn, JM, Jay, N, Stier, EA, Logan, JS, Einstein, MH, Saah, A, Mitsuyasu, RT, Aboulafia, D, Palefsky, JM & Wilkin, TJ 2018, 'A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men', Papillomavirus Research, vol. 6, pp. 11-14. https://doi.org/10.1016/j.pvr.2018.05.001

TY - JOUR

T1 - A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected men

AU - Ellsworth, G. B.

AU - Lensing, S. Y.

AU - Ogilvie, C. B.

AU - Lee, J. Y.

AU - Goldstone, S. E.

AU - Berry-Lawhorn, J. M.

AU - Jay, N.

AU - Stier, E. A.

AU - Logan, J. S.

AU - Einstein, M. H.

AU - Saah, A.

AU - Mitsuyasu, R. T.

AU - Aboulafia, D.

AU - Palefsky, J. M.

AU - Wilkin, T. J.

N1 - Funding Information: National Institutes of Health [K23 AI 55038 to T.J.W., UL1 RR024996 to Weill Cornell Clinical and Translational Science Center, U01 CA121947–01 to R.T.M., M01-RR00865 to Weill Cornell Clinical and Translational Science Center, T32 AI007613 to Division of Infectious Diseases of Weill Cornell Medical College, and UL1 RR024131 to University of California at San Francisco Clinical and Translational Science Institute]. Merck Laboratories provided funding for the HPV antibody assays and provided the vaccine doses for this study. Funding Information: Mark H. Einstein has advised or participated in educational speaking activities but not received an honorarium from Merck; Montefiore Medical Center had received payment for time spent by M.H.E. for these activities; Montefiore Medical Center has received grant funding from Merck for research-related costs of clinical trials for which M.H.E. was primary investigator. Alfred Saah is an employee of Merck Laboratories and owns stock in Merck Laboratories. Joel M. Palefsky has served as a consultant for Merck; University of California at San Francisco has received grant funding from Merck for advisory board activities of J.M.P. and for research-related costs of clinical trials for which J.M.P. was the primary investigator. Timothy J. Wilkin has served as an ad hoc advisor for GlaxoSmit hKl ine/ViiV Healthcare, and has received grant funding (paid to Weill Cornell Medicine) from GlaxoSmit hKl ine/ViiV Healthcare.

PY - 2018/12

Y1 - 2018/12

UR - http://www.scopus.com/inward/record.url?scp=85048803025&partnerID=8YFLogxK

U2 - 10.1016/j.pvr.2018.05.001

DO - 10.1016/j.pvr.2018.05.001

M3 - Article

C2 - 29807211

AN - SCOPUS:85048803025

SN - 2666-6790

VL - 6

SP - 11

EP - 14

JO - Papillomavirus Research

JF - Papillomavirus Research

ER -